TrialClinical drug investigation2011

Oral L-ornithine-L-aspartate improves health-related quality of life in cirrhotic patients with hepatic encephalopathy: an open-label, prospective, multicentre observational study.

Janus P Ong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.